Cargando…

Fondaparinux versus Enoxaparin - Which is the Best Anticoagulant for Acute Coronary Syndrome? - Brazilian Registry Data

BACKGROUND: Recent studies have shown fondaparinux's superiority over enoxaparin in patients with non-ST elevation acute coronary syndrome (ACS), especially in relation to bleeding reduction. The description of this finding in a Brazilian registry has not yet been documented. OBJECTIVE: To comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soeiro, Alexandre de Matos, Silva, Pedro Gabriel Melo de Barros e, Roque, Eduardo Alberto de Castro, Bossa, Aline Siqueira, César, Maria Cristina, Simões, Sheila Aparecida, Okada, Mariana Yumi, Leal, Tatiana de Carvalho Andreucci Torres, Pedroti, Fátima Cristina Monteiro, de Oliveira Jr., Múcio Tavares
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053192/ https://www.ncbi.nlm.nih.gov/pubmed/27579543 http://dx.doi.org/10.5935/abc.20160127

Ejemplares similares

Mortality reduction with use of oral beta-blockers in patients with acute coronary syndrome
por: de Matos Soeiro, Alexandre, et al.
Publicado: (2016)

Sensitive Troponin I Assay in Patients with Chest Pain - Association with Significant Coronary Lesions with or Without Renal Failure
por: Soeiro, Alexandre de Matos, et al.
Publicado: (2018)

Prognostic Differences between Men and Women with Acute Coronary Syndrome. Data from a Brazilian Registry
por: Soeiro, Alexandre de Matos, et al.
Publicado: (2018)

Is There Any Relationship between TSH Levels and Prognosis in Acute Coronary Syndrome?
por: Soeiro, Alexandre de Matos, et al.
Publicado: (2018)

Complete Treatment Versus Residual Lesion - Long-Term Evolution After Acute Coronary Syndrome
por: Soeiro, Alexandre de Matos, et al.
Publicado: (2016)

The hazard of fondaparinux in non-critically ill patients with COVID-19: Retrospective controlled study versus enoxaparin
por: Prandoni, Paolo, et al.
Publicado: (2020)

Patient with Atrial Myxoma and Signs of Obstruction of the Left Ventricular Outflow Tract
por: Freire, Antonio Fernando Diniz, et al.
Publicado: (2017)

Postoperative decreased levels of D-dimer in patients with gynecologic cancer with enoxaparin and fondaparinux thromboprophylaxis
por: KODAMA, JUNICHI, et al.
Publicado: (2013)

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

Antithrombotic and Anti-Inflammatory Effects of Fondaparinux and Enoxaparin in Hospitalized COVID-19 Patients: The FONDENOXAVID Study
por: Cardillo, Giuseppe, et al.
Publicado: (2021)

Enoxaparin-sodium/fondaparinux-sodium: Major and clinically relevant bleeding complications: 8 case reports
Publicado: (2020)

Fondaparinux vs. enoxaparin for the prevention of venous thromboembolism after total hip replacement: A meta-analysis
por: Dong, Wen-Jun, et al.
Publicado: (2016)

Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study
por: Russo, Vincenzo, et al.
Publicado: (2020)

Cost-effectiveness of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome in Canada (OASIS-5)
por: Alfonso Ross Terres, Jorge, et al.
Publicado: (2015)

Choosing between Enoxaparin and Fondaparinux for the management of patients with acute coronary syndrome: A systematic review and meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

Desempenho Diagnóstico da Angiotomografia Computadorizada e da Avaliação Seriada de Troponina Cardíaca Sensível em Pacientes com Dor Torácica e Risco Intermediário para Eventos Cardiovasculares
por: Soeiro, Alexandre de Matos, et al.
Publicado: (2022)

Silver-assisted gold-catalyzed formal synthesis of the anticoagulant Fondaparinux pentasaccharide
por: Walke, Gulab, et al.
Publicado: (2021)

Clinical characteristics and long-term progression of young patients with acute coronary syndrome in Brazil
por: Soeiro, Alexandre de Matos, et al.
Publicado: (2015)

The Fondaparinux Paradox: Fondaparinux-Related Heparin-induced Thrombocytopenia
por: Vadi, Sonali, et al.
Publicado: (2018)

Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
por: Serrano Jr., Carlos V., et al.
Publicado: (2019)

The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist
por: Shimizu, Kazuhiro, et al.
Publicado: (2018)

Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban
por: Zhao, Xin, et al.
Publicado: (2016)

Extended Physicochemical Characterization of the Synthetic Anticoagulant Pentasaccharide Fondaparinux Sodium by Quantitative NMR and Single Crystal X-ray Analysis
por: de Wildt, William, et al.
Publicado: (2017)

Effectiveness and Tolerability of Fondaparinux vs Enoxaparin in a Population of Indian Patients with Symptomatic Deep Vein Thrombosis: A Retrospective Real-World Study
por: Ramakrishna, Pinjala, et al.
Publicado: (2021)

Fondaparinux-associated Thrombocytopenia
por: Malik, Jahanzeb, et al.
Publicado: (2021)

When Will Fondaparinux Induce Thrombocytopenia?
por: Chen, Li-Yu, et al.
Publicado: (2022)

Design and Synthesis of Neutralizable Fondaparinux
por: Zhang, Liangwei, et al.
Publicado: (2022)

Use of Molecular Dynamics for the Refinement of an Electrostatic Model for the In Silico Design of a Polymer Antidote for the Anticoagulant Fondaparinux
por: Cajiao, Adriana, et al.
Publicado: (2013)

Anticoagulant therapy with fondaparinux in a liver transplant patient with thrombosis and liver fibrosis: a case report
por: Cafolla, Arturo, et al.
Publicado: (2017)

Intracardiac embolization of inferior vena cava filter associated with right atrium perforation and cardiac tamponade
por: Soeiro, Alexandre de Matos, et al.
Publicado: (2014)

Clinical manifestations and pulmonary histopathological analysis related to different diseases in patients with fatal pulmonary thromboembolism: an autopsy study
por: Ruppert, Aline Domingos Pinto, et al.
Publicado: (2014)

The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false‐positive results?
por: De Kesel, Pieter M.M., et al.
Publicado: (2019)

Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008)

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
por: Inchiosa, Mario A., et al.
Publicado: (2012)

Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?
por: Honore, Patrick M., et al.
Publicado: (2016)

Management of acute coronary syndromes with fondaparinux
por: Wienbergen, Harm, et al.
Publicado: (2007)

Thromboelastographic monitoring of fondaparinux in surgical patients
por: Martinez, B, et al.
Publicado: (2013)

Efficacy and safety of bivalirudin bridging enoxaparin versus fondaparinux in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: evidence from a single-center study
por: Guo, Yanqing, et al.
Publicado: (2023)

Endocardite por Coxiella Burnetii: A Tomografia por Emissão de Pósitrons pode ser uma Alternativa ao Diagnóstico?
por: Mizuta, Marjorie Hayashida, et al.
Publicado: (2022)

Prophylactic anticoagulation with low dose enoxaparin: is the subcutaneous route appropriate in the critically ill?
por: Priglinger, U, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_ku19l3q1kk7il0g17sfl9jd5fc